1124 related articles for article (PubMed ID: 20467602)
1. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects. A Cochrane systematic review.
Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
Eur J Oral Implantol; 2009; 2(4):247-66. PubMed ID: 20467602
[TBL] [Abstract][Full Text] [Related]
2. Enamel matrix derivative (Emdogain(R)) for periodontal tissue regeneration in intrabony defects.
Esposito M; Grusovin MG; Papanikolaou N; Coulthard P; Worthington HV
Cochrane Database Syst Rev; 2009 Oct; 2009(4):CD003875. PubMed ID: 19821315
[TBL] [Abstract][Full Text] [Related]
3. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.
Esposito M; Grusovin MG; Coulthard P; Worthington HV
Cochrane Database Syst Rev; 2005 Oct; (4):CD003875. PubMed ID: 16235343
[TBL] [Abstract][Full Text] [Related]
4. Enamel matrix derivative (Emdogain) for periodontal tissue regeneration in intrabony defects.
Esposito M; Coulthard P; Worthington HV
Cochrane Database Syst Rev; 2003; (2):CD003875. PubMed ID: 12804493
[TBL] [Abstract][Full Text] [Related]
5. Enamel matrix derivative for periodontal tissue regeneration in treatment of intrabony defects: a Cochrane systematic review.
Esposito M; Coulthard P; Thomsen P; Worthington HV
J Dent Educ; 2004 Aug; 68(8):834-44. PubMed ID: 15286106
[TBL] [Abstract][Full Text] [Related]
6. Guided tissue regeneration for periodontal infra-bony defects.
Needleman IG; Worthington HV; Giedrys-Leeper E; Tucker RJ
Cochrane Database Syst Rev; 2006 Apr; (2):CD001724. PubMed ID: 16625546
[TBL] [Abstract][Full Text] [Related]
7. Autologous platelet concentrates for treating periodontal infrabony defects.
Del Fabbro M; Karanxha L; Panda S; Bucchi C; Nadathur Doraiswamy J; Sankari M; Ramamoorthi S; Varghese S; Taschieri S
Cochrane Database Syst Rev; 2018 Nov; 11(11):CD011423. PubMed ID: 30484284
[TBL] [Abstract][Full Text] [Related]
8. Guided tissue regeneration for periodontal infra-bony defects.
Needleman IG; Giedrys-Leeper E; Tucker RJ; Worthington HV
Cochrane Database Syst Rev; 2001; (2):CD001724. PubMed ID: 11406001
[TBL] [Abstract][Full Text] [Related]
9. WITHDRAWN: Guided tissue regeneration for periodontal infra-bony defects.
Needleman I; Worthington HV; Giedrys-Leeper E; Tucker R
Cochrane Database Syst Rev; 2019 May; 5(5):CD001724. PubMed ID: 31141165
[TBL] [Abstract][Full Text] [Related]
10. Treatment of intrabony defects using guided tissue regeneration or enamel matrix derivative: a 3-year prospective randomized clinical study.
Crea A; Dassatti L; Hoffmann O; Zafiropoulos GG; Deli G
J Periodontol; 2008 Dec; 79(12):2281-9. PubMed ID: 19053918
[TBL] [Abstract][Full Text] [Related]
11. Clinical outcomes after treatment of non-contained intrabony defects with enamel matrix derivative or guided tissue regeneration: a 12-month randomized controlled clinical trial.
Siciliano VI; Andreuccetti G; Siciliano AI; Blasi A; Sculean A; Salvi GE
J Periodontol; 2011 Jan; 82(1):62-71. PubMed ID: 20809859
[TBL] [Abstract][Full Text] [Related]
12. Five-year clinical results for treatment of intrabony defects with EMD, guided tissue regeneration and open-flap debridement: a case series.
Mitani A; Takasu H; Horibe T; Furuta H; Nagasaka T; Aino M; Fukuda M; Fujimura T; Mogi M; Noguchi T
J Periodontal Res; 2015 Feb; 50(1):123-30. PubMed ID: 24815103
[TBL] [Abstract][Full Text] [Related]
13. The use of enamel matrix derivative in the treatment of periodontal defects: a literature review and meta-analysis.
Venezia E; Goldstein M; Boyan BD; Schwartz Z
Crit Rev Oral Biol Med; 2004 Nov; 15(6):382-402. PubMed ID: 15574680
[TBL] [Abstract][Full Text] [Related]
14. Does enamel matrix derivative application provide additional clinical benefits in residual periodontal pockets associated with suprabony defects? A systematic review and meta-analysis of randomized clinical trials.
Graziani F; Gennai S; Cei S; Ducci F; Discepoli N; Carmignani A; Tonetti M
J Clin Periodontol; 2014 Apr; 41(4):377-86. PubMed ID: 24329867
[TBL] [Abstract][Full Text] [Related]
15. Comparison of clinical, radiographic, and histometric measurements following treatment with guided tissue regeneration or enamel matrix proteins in human periodontal defects.
Windisch P; Sculean A; Klein F; Tóth V; Gera I; Reich E; Eickholz P
J Periodontol; 2002 Apr; 73(4):409-17. PubMed ID: 11990442
[TBL] [Abstract][Full Text] [Related]
16. Early wound healing outcomes after regenerative periodontal surgery with enamel matrix derivatives or guided tissue regeneration: a systematic review.
Rojas MA; Marini L; Pilloni A; Sahrmann P
BMC Oral Health; 2019 May; 19(1):76. PubMed ID: 31064353
[TBL] [Abstract][Full Text] [Related]
17. Deproteinized bovine bone in association with guided tissue regeneration or enamel matrix derivatives procedures in aggressive periodontitis patients: a 1-year retrospective study.
Artzi Z; Tal H; Platner O; Wasersprung N; Weinberg E; Slutzkey S; Gozali N; Carmeli G; Herzberg R; Kozlovsky A
J Clin Periodontol; 2015 Jun; 42(6):547-56. PubMed ID: 25950086
[TBL] [Abstract][Full Text] [Related]
18. Treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration. A prospective controlled clinical study.
Sculean A; Windisch P; Chiantella GC; Donos N; Brecx M; Reich E
J Clin Periodontol; 2001 May; 28(5):397-403. PubMed ID: 11350501
[TBL] [Abstract][Full Text] [Related]
19. Addition of enamel matrix derivatives to bone substitutes for the treatment of intrabony defects: A systematic review, meta-analysis and trial sequential analysis.
Troiano G; Laino L; Zhurakivska K; Cicciù M; Lo Muzio L; Lo Russo L
J Clin Periodontol; 2017 Jul; 44(7):729-738. PubMed ID: 28477366
[TBL] [Abstract][Full Text] [Related]
20. Five-year results following treatment of intrabony defects with enamel matrix proteins and guided tissue regeneration.
Sculean A; Donos N; Schwarz F; Becker J; Brecx M; Arweiler NB
J Clin Periodontol; 2004 Jul; 31(7):545-9. PubMed ID: 15191590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
